...
First Name | Last Name | Organization |
|---|---|---|
Adam | Roose | AAIH |
Adrian | Lubinski | GSK |
Szczepan | Baran | Novartis |
Swen-Eric | Schelhorn | Merck |
Sujeegar | Jeevanandam | Zifo |
Loganathan | Kumarasamy | Zifo |
Simon | Thornber | GSK |
Stephen | Amato | Northeastern Univ |
Morrie | Ruffin | Adjuvant |
M | Remer | M. Remer Consulting |
Markus | Blank | Bayer |
Andrew | Conkie | Red Star Consulting |
Brandon | Allgood Integral | TXValo Inc |
The first call for the CoI was on October 14, 2020. The main action item from this call is to make contact with other organizations; in particular, Artificial Intelligence Medical Devices (AIMDs, http://www.imdrf.org/workitems/wi-aimd.asp), CONSORT Ai Working Group, and the AAIH. A representative of AAIH was invited to our meeting, but could not make the time, and I (VM) caught up with him afterwards. The grand objective is to invite government regulator reps to a web panel.
...